Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery
Notice NOT-AI-22-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2021 Category: Research Source Type: funding
Notice of Early Expiration of PA-19-077, Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)"
Notice NOT-AI-22-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2021 Category: Research Source Type: funding
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-064 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support research to advance understanding of the underlying immune mechanisms that contribute to malaria vaccine-elicited protection or vaccine hypo-responsiveness in endemic regions by capitalizing on recent research advances in systems vaccinology and systems immunology as well as emerging opportunities in data science and informatics. Multidisciplinary science and collaboration among investigators from the malaria vaccine research field and other relevant scientific areas are highly encouraged. The goal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2020 Category: Research Source Type: funding
Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2020 Category: Research Source Type: funding
Clarification of Research Areas for NIAID RFA-AI-19-059: Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed)
Notice NOT-AI-20-006 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 30, 2019 Category: Research Source Type: funding
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-059 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to stimulate basic research, discovery, and early translational research to enable and accelerate the generation of highly efficacious pre-erythrocytic stage, sporozoite-based vaccines. Cross-fertilization and collaboration among investigators from malaria vaccine research and other basic research areas such as parasite biology, parasite genomics, pathogenesis, and host immunology are highly encouraged. The goal is to generate one or more promising vaccine candidates against human malaria that exhibit perform...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 11, 2019 Category: Research Source Type: funding
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Funding Opportunity PA-19-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding
Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-046 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine Treatment and Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding
Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-047 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to form a Leadership Group for an Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), to support the planning and implementation of clinical research that addresses the scientific priorities of NIAID in evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases. A companion FOA sol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
Funding Opportunity Number: PA-13-179 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the...
Source: Grants.gov - April 5, 2016 Category: Research Tags: Health Source Type: funding
Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention
Funding Opportunity Number: RFA-GH-15-0060102SUPP16 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.326Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Feb 23, 2016Award Ceiling: $0Expected Number of Awards: 1Creation Date: Dec 22, 2015Funding Opportunity Description: The purpose of this cooperative agreement is to 1) conduct operations research in malaria in sub- Saharan Africa and Asia, 2) su...
Source: Grants.gov - December 23, 2015 Category: Research Tags: Health Source Type: funding
An Opportunity to Collaborate and Use the Unique Resources of the NIH Clinical Center
Three years ago, NIH created a program to enable extramural researchers to collaborate with our intramural scientists and use the exceptional resources of the NIH Clinical Center. Since then, 20 awards have been made to support projects of significant breadth, such as a trial for treatment of relapsed leukemia; a malaria vaccine trial; and a trial testing a new cardiac catheter. This is the fourth year that NIH has issued this funding opportunity. The December 15 pre-application deadline is approaching, and I wanted to remind you what this program offers.
As described in the funding opportunity announcements (FOAs) (PAR 15...
Source: NIH Extramural Nexus - November 18, 2015 Category: Research Authors: Mike Lauer Tags: blog Open Mike Award Programs Clinical Center Source Type: funding
Establishment of Centers of Excellence in Refugee Health
Funding Opportunity Number: CDC-RFA-CK15-1503 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.283Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(...
Source: Grants.gov - March 24, 2015 Category: Research Tags: Health Source Type: funding
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a Malaria-Endemic Area of Malawi with High HIV Prevalence
Funding Opportunity Number: RFA-IP-14-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.083Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Jan 13, 2014Award Ceiling: $1,200,000Expected Number of Awards: 1Creation Date: Nov 14, 2013Funding Opportunity Description: The NCIRD Influenza Division (ID) is seeking a cooperative agreement with the University of Liverpool, Liverpool School of Tropical...
Source: Grants.gov - November 14, 2013 Category: Research Tags: Health Source Type: funding
